Description
This oral capsule brings together BPC-157, a gastric-derived pentadecapeptide, and TB-500, an actin-regulating thymosin beta-4 fragment, in a solid-dose research preparation.
Laboratory studies in cell and animal models have explored angiogenesis, cell migration, matrix turnover, and inflammatory signaling. The encapsulated pairing supports oral-route and combined-peptide research designs.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.